The U.S. Department of Health and Human Services is funding research at Rutgers University on how to increase uptake of Merck’s human papillomavirus, or HPV, vaccine among Black adolescents, documents obtained by Children’s Health Defense via a Freedom of Information Act request revealed.

HHS awarded the $600,000, three-year, grant, which will be administered by the National Cancer Institute (NCI), to Racquel Elizabeth Kohler, Ph.D.

It is one of nearly 50 grants identified by CHD in June — totaling more than $40 million — awarded by HHS to universities, healthcare systems and departments of public health to increase HPV vaccine uptake among adolescents.

The National Institutes of Health developed the HPV vaccine technology, which it licensed exclusively to Merck — the only pharmaceutical company licensed to produce the HPV vaccine in the U.S.

More than 80 lawsuits against Merck are pending in federal court for vaccine injuries associated with its Gardasil HPV vaccine.

https://childrenshealthdefense.org/defender/hhs-rutgers-hpv-vaccine-black-parents/?